Comment on What Gives With Portola Pharmaceuticals?

What Gives With Portola Pharmaceuticals?

A surprising FDA rejection of its most advanced drug candidate caused Portola Pharmaceuticals (NASDAQ: PTLA) shares to crater. What derailed Portola Pharmaceuticals' application for approval, and can this company get itself back on track?In this clip from The Motley Fool's Industry Focus: Healthcare podcast, analyst Kristine Harjes and contributor Todd Campbell discuss whether Portola Pharmaceuticals' hiccup means this drug will never see the light of day.A full transcript follows the video.Continue reading

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News